IRIS
ANSALDI, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.573
AS - Asia 2.741
NA - Nord America 1.180
SA - Sud America 274
AF - Africa 48
OC - Oceania 4
Totale 31.820
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 27.039
SG - Singapore 1.231
US - Stati Uniti d'America 1.119
CN - Cina 732
VN - Vietnam 481
FR - Francia 239
BR - Brasile 181
HK - Hong Kong 83
DE - Germania 66
AR - Argentina 53
FI - Finlandia 50
GB - Regno Unito 37
JP - Giappone 30
BD - Bangladesh 28
IQ - Iraq 26
MX - Messico 24
CH - Svizzera 21
ID - Indonesia 20
IN - India 20
NL - Olanda 20
CA - Canada 18
RU - Federazione Russa 14
IE - Irlanda 12
ZA - Sudafrica 11
ES - Italia 10
PH - Filippine 10
CO - Colombia 9
MA - Marocco 9
PK - Pakistan 9
PL - Polonia 9
UA - Ucraina 9
EC - Ecuador 8
SA - Arabia Saudita 8
CL - Cile 7
UZ - Uzbekistan 7
PY - Paraguay 6
SE - Svezia 6
TN - Tunisia 6
TR - Turchia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
KE - Kenya 5
LB - Libano 5
NP - Nepal 5
RO - Romania 5
TT - Trinidad e Tobago 5
EG - Egitto 4
GR - Grecia 4
HR - Croazia 4
MY - Malesia 4
OM - Oman 4
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
ET - Etiopia 3
IL - Israele 3
RS - Serbia 3
AT - Austria 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IS - Islanda 2
KR - Corea 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
TG - Togo 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
GM - Gambi 1
GP - Guadalupe 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
SI - Slovenia 1
SR - Suriname 1
Totale 31.817
Salva come PNG Salva come JPEG
Città #
Genova 15.580
Genoa 6.742
Rapallo 2.510
Vado Ligure 1.787
Singapore 569
San Jose 463
Bordighera 271
Lauterbourg 218
Ho Chi Minh City 158
Ashburn 110
Beijing 99
Hanoi 95
Hong Kong 80
Council Bluffs 70
New York 69
Frankfurt am Main 54
Santa Clara 51
Helsinki 46
Milan 26
Tokyo 26
Da Nang 24
Tianjin 23
São Paulo 22
Los Angeles 21
Zurich 21
Orem 19
Haiphong 18
Mexico City 16
Amsterdam 15
Buffalo 12
Baghdad 11
Dublin 11
Biên Hòa 10
City of London 10
Rome 10
Hải Dương 9
London 9
Atlanta 7
Can Tho 7
Dallas 7
Montreal 7
Paris 7
Turin 7
Warsaw 7
Brasília 6
Cardiff 6
Castelluccio dei Sauri 6
Chennai 6
Chicago 6
Dhaka 6
Guangzhou 6
Quảng Ngãi 6
Rio de Janeiro 6
Jeddah 5
Johannesburg 5
Nha Trang 5
Stockholm 5
Tashkent 5
Thái Nguyên 5
Asunción 4
Buenos Aires 4
Charlotte 4
Curitiba 4
Hangzhou 4
Houston 4
Kyiv 4
Lappeenranta 4
Madrid 4
Manaus 4
Nairobi 4
Naples 4
Osasco 4
Phoenix 4
Phủ Lý 4
Quito 4
Shanghai 4
Surabaya 4
Toronto 4
Addis Ababa 3
Athens 3
Baku 3
Belgrade 3
Belo Horizonte 3
Bắc Giang 3
Bắc Ninh 3
Cape Town 3
Casablanca 3
Catania 3
Changsha 3
Denver 3
Dubai 3
Duque de Caxias 3
Florence 3
González Catán 3
Guaporé 3
Guayaquil 3
Lahore 3
Lấp Vò 3
Manila 3
Marseille 3
Totale 29.560
Salva come PNG Salva come JPEG
Nome #
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection 492
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy 248
Influenza vaccination among healthcare workers in Italy. 241
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. 232
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 219
Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. 214
Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines. 214
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 214
Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis 213
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 207
Assessment of knowledge, attitudes, and propensity towards HPV vaccine of young adult students in Italy 207
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 206
Ras-induced resistance to lapatinib is overcome by MEK inhibition 199
Vaccine-preventable infections in Systemic Lupus Erythematosus 196
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 195
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. 193
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 191
Analysis of a 3-months measles outbreak in western Liguria, Italy: Are hospital safe and healthcare workers reliable? 189
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 186
Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives 183
A meningococcal carrier survey, in Italy 179
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine 178
An unexpected Streptococcus pneumoniae strain. 177
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 172
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 171
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies 171
Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis 171
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 169
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 168
Inactivated influenza vaccines: recent progress and implications for the elderly 166
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 165
A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months 164
Increasing Incidence of Streptococcus pneumoniae Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine. 162
Universal influenza virus vaccines: what needs to happen next? 162
Surgical Prevention of Arm Lymphedema After Breast Cancer Treatment 161
The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis 160
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 159
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 159
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 159
Burden and prevention of hpv. Knowledge, practices and attitude assessment among pre-adolescents and their parents in Italy 159
Neutralizing and Hemagglutination-Inhibiting Activities of Antibodies Elicited by the 2004-2005 Influenza Vaccine against Drifted Viruses. 158
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization 158
Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy 157
Impatto della pertosse nella popolazione e strategie di prevenzione vaccinale 155
Antiviral activity of amantadine in elderly patients with chronic hepatitis C 155
An outbreak of hepatitis C virus in a haemodialysis unit: molecular evidence of patient-to-patient transmission 154
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy) 153
Seasonal influenza beginning in Europe: report from EISS. 152
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. 152
Direct detection of Bordetella pertussis and Bordetella parapertussis: comparison of polymerase chain reaction and culture. 150
SARS-CoV, influenza A and syncitial respiratory virus resistance against common disinfectants and ultraviolet irradiation 150
Fluzone® intra-dermal (Intanza® / Istivac® Intra-dermal): An updated overview 150
An outbreak of influenza in a residential drug-rehabilitation community 149
Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation. 148
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. 148
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 148
Epidemiology of viral respiratory tract infections in an outpatient haematology facility 148
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement 147
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy 147
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 147
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 146
Infective endocarditis in elderly: An Italian prospective multi-center observational study 145
Immunomodulation due to plasma or plasma-platelet apheresis donation: Events occurring during donation procedures. 144
Determinants of invasiveness and ability to cause invasive pneumococcal disease, pneumonia and acute otitis media of different serotypes of Streptococcus pneumoniae. 144
MOLECULAR AND SEROLOGICAL DIVERSITY OF NEISSERIA MENINGITIDIS CARRIER STRAINS ISOLATED FROM ITALIAN STUDENTS AGED 14-22 YEARS. 144
High-dose daptomycin in documented Staphylococcus aureus infections. 144
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study 144
Measles outbreak in Grosseto, central Italy, 2006. 143
Vaccinazione antinfluenzale degli operatori sanitari presso l’IRCCS AOU San Martino-IST di Genova: progetto-pilota di counselling e offerta attiva direttamente presso reparti a elevato rischio 142
Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults 141
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 141
Clinical and therapeutic aspects of candidemia: A five year single centre study 141
r-IFN alfa-2b/ribavirin combined therapy followed by low dose of IFN alfa 2b in chronic hepatitis C IFN nonresponders 140
Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy 140
Influenza control in the 21st century: Optimizing protection of older adults 139
Fluzone® Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults 139
Pneumococcus and the elderly in Italy: A summary of available evidence regarding carriage, Clinical burden of lower respiratory tract infections and on-field effectiveness of PCV13 vaccination 139
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 138
Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: relationship with steatosis 138
Sequentialoutbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation 138
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability. 138
Bacterial carriage and respiratory tract infections in subjects ≥ 60 years during an influenza season: implications for the epidemiology of Community Acquired Pneumonia and influenza vaccine effectiveness 138
Vaccination recommendations for patients with neuromuscular disease. 137
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 137
Simultaneous Detection of Anti-HCV Antibody and HCV Core Antigen. 136
A possible role of soluble HLA-I molecule in the immunomodulatory effects of therapeutic apheresis. 136
Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view. 136
Safety and immunogenicity of conventional subunit and MF-59 adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients 136
Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria, Italy 136
Italian health care workers’ knowledge, attitudes, and practices regarding human papillomavirus infection and prevention 136
Pneumococcal vaccination in Europe: schedule adherence. 135
Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains 134
Relationship between laboratory parameters and intensive care unit stay post-liver transplantation: proposal of a model. 133
Latent tuberculosis infection among a large cohort of medical students at a teaching hospital in Italy 133
A novel approach to reduce the hepatitis C virus window period: clinical evaluation of a new ELISA assay for HCV core antigen 132
New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season 132
Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases 132
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season 132
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study 132
Identification of key mutations in HIV Reverse Transcriptase gene can influence the clinical outcome of HAART 131
Totale 16.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.270
article - articoli 90.907
book - libri 0
conference - conferenze 7.130
curatela - curatele 0
other - altro 250
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.983
Totale 204.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021464 0 0 0 0 0 0 0 0 0 178 130 156
2021/20222.906 60 171 297 371 84 173 174 769 149 229 107 322
2022/20232.988 299 216 28 293 481 566 27 227 491 31 295 34
2023/20241.660 76 217 29 184 118 239 60 355 104 21 74 183
2024/20254.569 164 337 123 319 560 485 459 701 170 224 436 591
2025/20267.075 940 234 578 587 1.014 791 1.292 371 662 606 0 0
Totale 32.105